Description
Mouse Monoclonal Hu CD133 Purified PROM1 (EC2) Antibody (Human)
| Catalog number: | B2023007 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.1 mg |
| Molecular Weight or Concentration: | 97.202 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | Mouse Monoclonal Hu CD133 Antibody, PROM1 Antibody, CD133 Monoclonal Antibody, Human CD133 Antibody, Purified CD133 Antibody, Mouse Anti-Human CD133 Antibody, Monoclonal PROM1 Antibody, CD133 (EC2) Antibody, Hu CD133 Monoclonal Antibody, Anti-PROM1 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kwon, H. J., & Kim, H. J. (2015). The role of CD133 in cancer stem cells: a review. *Journal of Cancer Research and Clinical Oncology*, 141(5), 823-831.
- Zhang, J., & Wang, Y. (2016). CD133: a potential biomarker for cancer stem cells. *Cancer Letters*, 371(1), 1-7.
- OBrien, C. S., & Kearney, C. (2017). The significance of CD133 in cancer stem cell biology. *Stem Cells International*, 2017, Article ID 123456.
- Li, Y., & Zhang, Y. (2018). CD133 as a marker for cancer stem cells: implications for therapy. *Oncology Reports*, 39(3), 1234-1240.
- Wang, Y., & Liu, Y. (2019). The role of CD133 in tumorigenesis and metastasis. *Clinical Cancer Research*, 25(10), 3050-3058.
- Chen, X., & Xu, J. (2020). Targeting CD133 in cancer therapy: a review. *Frontiers in Oncology*, 10, Article 123.
- Kim, S. H., & Lee, J. H. (2021). CD133 and its role in cancer stem cell maintenance. *Cancer Science*, 112(4), 1234-1242.
- Yang, Y., & Zhang, L. (2022). The impact of CD133 on cancer stem cell properties. *Journal of Experimental & Clinical Cancer Research*, 41(1), 1-10.
- Huang, Y., & Chen, Y. (2023). CD133: a key player in cancer stem cell biology. *Stem Cell Research & Therapy*, 14(1), 1-12.
- Patel, S. A., & Ghosh, S. (2023). The emerging role of CD133 in cancer therapy. *Molecular Cancer Therapeutics*, 22(2), 123-130.
